Abstract
Blood and marrow transplantation is a highly complex process requiring a coordinated team from many disciplines all contributing to the treatment and outcome of the transplant recipient. The focus of this highly specialized community has been to improve outcomes and widen the field of candidates for this often life-saving but high-risk procedure.
The chapter will examine the evolution of the most common citations during inspections for accreditation under the FACT-JACIE Hematopoietic Cellular Therapy Standards, currently in version 6.1 as of this writing. For each area of citations, methods to integrate into the collection of hematopoietic progenitor cell (HPC) products to address and avoid these citations as well as to provide high-quality cells to patients will be discussed. The trends discussed in this chapter reflect inspections performed by the Foundation for Accreditation of Cellular Therapy (FACT).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Reference
FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration, Seventh Edition, March 2018
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gastineau, D.A., Wacker, K.K. (2020). FACT-JACIE Standards: Common Citations and How Best to Avoid Them. In: Abutalib, S., Padmanabhan, A., Pham, H., Worel, N. (eds) Best Practices of Apheresis in Hematopoietic Cell Transplantation. Advances and Controversies in Hematopoietic Transplantation and Cell Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-55131-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-55131-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55130-2
Online ISBN: 978-3-319-55131-9
eBook Packages: MedicineMedicine (R0)